# SL Science Holding Limited (SLBT) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Healthcare / Biotechnology. Price $2.88, market value $1.6 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). SL Science Holding Limited reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **Price / sales: 735.0×**. Each dollar of revenue is priced at 735.0×, a level that requires very high margins or very fast growth to justify.
- **Price / book: 707.1×**. The shares trade at 707.1× book value; most of the value is in earnings power and intangibles rather than the balance sheet.
- **Free-cash-flow yield: -0.1%**. Free cash flow is negative: the business is consuming cash, which is normal for heavy investment phases but a warning otherwise.

## Profitability
- **Gross margin: 35.3%**. SL Science Holding Limited keeps 35.3% of revenue after the direct cost of what it sells.
- **Operating margin: -174.6%**. Operating margin is negative: the business loses money before interest and tax.
- **Net margin: -173.8%**. The company reported a net loss over the last twelve months.
- **Return on equity: -167.2%**. Return on equity is negative because earnings are negative.
- **Return on invested capital: -309.8%**. Return on all capital, debt included, is -309.8%: close to or below the cost of capital, so growth may not create value.
- **Return on assets: -135.6%**. Each dollar of assets produces -135.6% of profit.

## Growth
- **Revenue growth (1 yr): -34.7%**. Revenue fell 34.7% over the last year.

## Financial health
- **Debt to equity: 0.09**. Debt is 0.09 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.3×**. It would take 0.3 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 3.05** (quick 3.05). Current assets cover the next year's liabilities 3.05 times.
- **Piotroski F-score: 2/9**. 2 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend: none**. SL Science Holding Limited does not currently pay a dividend.

## Price and momentum
- **Total return (1 yr): -72.1%** (YTD -72.7%, 3-mo -70.6%). The shares are down 72.1% over twelve months including dividends.
- **From 52-week high: -80.1%** (14.7% above the low). Trading 80% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 47**. An RSI of 47 is neutral.
- **Beta (1 yr): 0.14** (volatility 211%). Beta of 0.14 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=SLBT · Page: https://foliofundamentals.com/stocks/slbt

Not investment advice.